Jane Street’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-21,001
Closed -$381K 8522
2020
Q3
$381K Buy
+21,001
New +$298K ﹤0.01% 5555
2018
Q2
Sell
-20,456
Closed -$524K 5887
2018
Q1
$524K Buy
+20,456
New +$440K ﹤0.01% 3432

Jane Street's AKCA Position: Q4 2020 in Review

Jane Street sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 21,001 shares — an estimated $381K sold.

Jane Street first reported a position in AKCA in Q1 2018 and held it in 2 quarters. The position peaked at $524K in Q1 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Jane Street reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Jane Street sold 21,001 Akcea Therapeutics Inc shares in Q4 2020, an estimated $381K.
  • Jane Street first reported a position in Akcea Therapeutics Inc in Q1 2018 and held it in 2 quarters.
  • Jane Street's Akcea Therapeutics Inc position peaked at $524K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.